The CAM resistance rate in Japan was 33% in 2015, with an increasing trend.
← all excerpts
The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on Helicobacter pylori Eradication.
1
—
—